Monitoring immune recovery on HIV therapy: critical, helpful, or waste of money in the current era?

AIDS. 2024 Jun 1;38(7):937-943. doi: 10.1097/QAD.0000000000003850. Epub 2024 Feb 1.

Authors

Margaretta Gergen¹, Austin Hewitt², Cristina B Sanger^{2

3}, Rob Striker⁴

Affiliations

¹ Department of Family Medicine.
² Department of Surgery.
³ Department of Surgery, W. S. Middleton Memorial Veterans' Hospital, Madison, WI, USA.
⁴ Division of Infectious Diseases, Department of Medicine, University of Wisconsin School of Medicine and Public Health.

No abstract available

Publication types

Editorial

MeSH terms

Anti-HIV Agents / economics
Anti-HIV Agents / therapeutic use
Anti-Retroviral Agents / economics
Anti-Retroviral Agents / therapeutic use
CD4 Lymphocyte Count
HIV Infections* / drug therapy
HIV Infections* / immunology
Humans
Monitoring, Immunologic

Substances

Anti-HIV Agents
Anti-Retroviral Agents